ecrin-mdr-crcClinical2022IPD Sharing (as of July 2023): UndecidedMetastatic Colorectal CancerColon CancerColorectal NeoplasmsRectal CancerMetastatic Colorectal CancerColon CancerColorectal NeoplasmsRectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2746205United States12ECRIN MDRRecruitingfalseA Study of CTX-009 in Adult Patients With Metastatic Colorectal CancerThis study is designed as an open-label, adaptive Simon Two-Stage study to evaluate the efficacy of CTX-009 in patients with metastatic colorectal cancer. A Simon Two-Stage adaptive design will enroll approximately 37 patients into Stage 1, and if criteria are met to move to Stage 2, an additional 47 patients will be enrolled.2022-12-152746205NCT05513742